title: Recombinant human activated protein C, package labeling, and hemorrhage risks.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Sweeney
authors.forename: Charles
authors.initials: C
authors.lastname: Natanson
authors.forename: Peter Q
authors.initials: PQ
authors.lastname: Eichacker
mesh_terms: D000890:Anti-Infective Agents / Q000009:adverse effects*; D004348:Drug Labeling; D006470:Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D011486:Protein C / Q000009:adverse effects*; D011994:Recombinant Proteins / Q000009:adverse effects; D012307:Risk Factors
chemical_list: D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated